Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

BCRXBCRX
6 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in BIOCRYST PHARMACEUTICALS INC

RA CAPITAL MANAGEMENT, L.P. holds 15.8M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $158.3M as of 2026-Q2. BCRX represents 1.4% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$158.3M

Current Shares

15.8M

Total Value Change

+$72.2M

Total Shares Change

+5.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
15.8M
0.0%
$158.3M1.4%$10.00
0
2026-Q1
Unchanged
15.8M
0.0%
$150.7M1.6%$9.52
0
2025-Q4
New
15.8M
-
$123.5M1.3%$7.80
69
2019-Q2
Exited
0
-100.0%
$00.0%$3.79
0
2019-Q1
Decreased
8.7M
-18.8%
$70.5M3.0%$8.14
0
2018-Q4
New
10.7M
-
$86M5.0%$8.07
93

Other major holders of BCRX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used